Definium Therapeutics Ownership & Insider Activity

Definium Therapeutics Inc

DFTXNASDAQ

$37.65

-2.67-6.62%

In chiusura: Sep 22, 5:00 PM EST

$38.19

-2.13-5.28%

Pre-mercato: 7:00 AM EST

Definium Therapeutics (DFTX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 4.6% of shares outstanding. Institutional investors hold 47.9%.

Shares Outstanding

132.743M

Shares Float

131.863M

Insider Shares Owned

4.999M

Insider % Owned

4.6%

Institutional Shares Held

64.358M

Institutional % Held

47.9%

Ownership Breakdown

Net Insider Activity by Month

Date	Insider	Title	Type	Shares	Price	Value
Sep 2, 2026	Robert Barrow	CHIEF EXECUTIVE OFFICER	GRANT	20.977K	$37.94	$722K
Jun 25, 2026	Mark Sullivan	CHIEF LEGAL OFFICER	SELL	13.008K	$45.03	$586K
Jun 25, 2026	Brandi Roberts	CHIEF FINANCIAL OFFICER	SELL	3.013K	$45.03	$136K
Jun 25, 2026	Robert Barrow	CHIEF EXECUTIVE OFFICER	SELL	29.208K	$45.03	$1.3M
Jun 25, 2026	Dan Karlin	CHIEF MEDICAL OFFICER	SELL	10.035K	$45.03	$452K
Jun 25, 2026	Matthew T Wiley	CHIEF COMMERCIAL OFFICER	SELL	2.867K	$45.03	$129K
Mar 25, 2026	Dan Karlin	CHIEF MEDICAL OFFICER	SELL	8.018K	$18.47	$148K
Mar 25, 2026	Mark Sullivan	CHIEF LEGAL OFFICER	SELL	10.702K	$18.47	$198K
Mar 25, 2026	Robert Barrow	CHIEF EXECUTIVE OFFICER	SELL	24.431K	$18.47	$451K